RAP 3.57% 14.5¢ resapp health limited

Well probably because he owns/CEO of Allure Capital (a boutique...

  1. 687 Posts.
    lightbulb Created with Sketch. 125
    Well probably because he owns/CEO of Allure Capital (a boutique investment firm) who is a top 20 holder of Alcidion. Furthermore he is an Executive Director, EVP Sales & Marketing for Alcidion. He is merely a Non Executive Director for RAP.

    Also, if you cared to do additional research, you will notice that he has posted about RAP on his Linkedin.

    Anyways I think being a CEO of a boutique investment firm he has enough on his plate and is not suited for the role, given that he won't be able to invest all his time into RAP. What we need is an individual who is willing to put in the effort/hours and all his/her focus into RAP. Still 4-5 months away from study results being released. Hopefully we can find a worthy individual for the role within the next 3 months (position was only recently being offered).

    1st wave of testing yielded good quality data (from check) - obviously translated into good results IMO and hence why RAP is confident enough to offer a new position/role in the business.
    Last edited by unknownshadow: 13/03/18
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.